医学
系统回顾
栓塞
科克伦图书馆
梅德林
纳入和排除标准
荟萃分析
腹主动脉瘤
外科
动脉瘤
放射科
随机对照试验
内科学
病理
替代医学
政治学
法学
作者
Marethania M. Akmal,Dara R. Pabittei,Tossapol Prapassaro,Raden Suhartono,Frans L. Moll,Joost A. van Herwaarden
标识
DOI:10.1016/j.ijsu.2021.106138
摘要
This systematic review shows that there is a wide variety of techniques to exclude a persistent type II endoleak. Different kinds of embolic agents have be used. Due to a lack of peer reviewed data on longterm follow-up, it was not possible to come to recommendations what treatment would be the best for a durable exclusion of a persistent type II endoleak after an initially successful EVAR. There remains an urgent need for proper executed studies, either randomized or with close observation in relation to longer follow-up.
科研通智能强力驱动
Strongly Powered by AbleSci AI